Christopher Antypas is currently serving as President at Asti's South Hills Pharmacy, a retail pharmacy that is pushing the boundaries of community pharmacy practice. A native of Pittsburgh, Chris earned his Doctor of Pharmacy from the University of Pittsburgh School of Pharmacy, and has extensive experience in a variety of pharmacy practice settings. In addition to his role at Asti's, he owns and operates 2 additional pharmacies in Pittsburgh, PA that each serve a unique patient population. His pharmacies include a specialty pharmacy that supports patients suffering from complex conditions by providing specialty therapies, as well as a long-term care pharmacy that services patients residing in a facility.
In addition to his experience as a business owner, manager, and clinician, Chris is practicing as a pharmacy consultant and adviser. He is presently the Director of Pharmacy Solutions for Henderson Brothers, Inc., an insurance and benefits brokerage/consulting firm in Pittsburgh. In this role, Chris helps to support large, self-funded employers manage their pharmacy benefit with thoughtful and innovative strategies.
Chris currently serves as a board member of the Pennsylvania Pharmacists Association and also sits on the advisory board for both Value Drug Company and Prescribe Wellness. He has been named as a Luminary for The Community Pharmacy Enhanced Service Network (CPESN) as well as The Pennsylvania Pharmacists Care Network (PPCN), and in this capacity, he is helping to reshape community pharmacy practice with innovation and cutting-edge pharmacy care. Known for his commitment to advance pharmacy practice, Chris has been invited to speak nationally and regionally on a variety of pharmacy topics. Chris was recently honored to be named the 2019 ‘Pharmacist of the Year’ by the Pennsylvania Pharmacists Association, and in October of 2020, Chris was named the 'Next Generation Pharmacist - Entrepreneur of the Year'.
Pharmacy has been a life's passion for Chris, and when he's not solving medication related problems, he enjoys every minute with his wife and 3 children in the South Hills of Pittsburgh.
Dr. Ilisa Bernstein is the SVP, Pharmacy Practice and Government Affairs at the American Pharmacists Association. Prior to that position, she was the Deputy Director of the Office of Compliance in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). She led this Office in promoting and protecting public health through outreach, strategies and actions that minimize consumer exposure to unsafe, ineffective and poor quality drugs. From 2006 to 2010, Ilisa was the Director of Pharmacy Affairs at FDA and from 1991-2002 and 2003-2006, she was a Senior Advisor in the Office of the Commissioner. From 2002 to 2003, Ilisa was a Senior Associate Director at Pfizer in the Regulatory Liaison Office in Rockville, Maryland. Ilisa started her career at FDA in 1988 as a Pharmacokinetic Reviewer in CDER.
Ilisa completed a post-doctoral residency at the National Institutes of Health, focusing on clinical and research pharmacokinetics. Ilisa received her PharmD from The University of Michigan College of Pharmacy and her JD from The American University Washington College of Law.
Ron Bone is a consultant in the area of Pharmaceutical Traceability and is currently focusing on the implementation of the U.S. 2013 Drug Quality and Security Act. Ron retired from McKesson Corporation where he held the position of Senior Vice President, Distribution Support. His responsibilities included Regulatory Affairs and leading McKesson's product security initiatives through the use of electronic track and trace.
Ron spent 41 years with McKesson Corporation in various operations, sales and financial management positions. He was a member of the of the GS1 Process Oversight Committee, a member of the Leadership Teams of GS1 Global Healthcare and GS1 US Healthcare, and was a member of the Industry Relations Council for the Healthcare Distribution Management Association (HDMA). In 2008, Bone testified before the U.S. House of Representatives, Energy and Commerce Committee as an industry expert on anti-counterfeiting. In 2007, he was the recipient of HDMA’s Nexus Award, which is the industry’s highest honor recognizing leadership, exemplary service and professional excellence.
Ron received his BS and MBA degrees from San Jose State University.
As a Director at Geisinger Health, Kevin utilizes Lean Thinking to focus on magnifying the value and eliminating the waste in the core value streams. Kevin’s evangelistic leadership style and manufacturing-based operational expertise, combined with his information systems background, has allowed him to stimulate new thinking and promotion of process redesign in Geisinger’s supply chain information and care support delivery systems. He is a foundational leader with the Healthcare Transformation Group (HTG), the Community Advisory Board (CAB) for GS1 U.S. Healthcare, and now serving on the Board of the newly formed Partnership for DSCSA Governance (PDG).He is active on multiple GS1, AHRMM, ASCx12, and C4SCS workgroups.He has completed AHRMM’s Healthcare Supply Chain Leadership Institute and completed his master’s degree in Project Management. In his spare time, he and his wife Diane, support their two son’s passion for cooking, and auto and motorcycle restoration.
y assurance, regulatory standards, and informatics experience in the pharmacy supply chain. Structured and led U.S. Department of Veterans Affairs (VA) formation of the National Pharmacy Benefits Management Strategic Health Group, Quality Assurance Team for the Consolidated Mail Outpatient Pharmacy, and supported Pharmacy Supply Chain and Regulatory Standards Adoption with the Office of Informatics & Analytics Bar Code Resource Office, GS1 US and Franciscan Missionaries of Our Lady Health System (FMOLHS) for traceability and compliance for Unique Device Identification (UDI), Drug Supply Chain Security Act (DSCSA) and United States Pharmacopeia (USP) Supply Chain Standards.
Anita T. Ducca is HDA’s Senior Vice President of Regulatory Affairs. She serves as the chief liaison and advocate on behalf of HDA with federal regulatory agencies, including FDA and DEA. She has been with the organization since 2002.
Prior to joining HDA, Ms. Ducca was the Director of Regulatory Affairs for the American Red Cross Biomedical Services (ARC), where she was responsible for internal and external regulatory, compliance and health and safety. Anita also served in a regulatory advocacy capacity for the American Petroleum Institute. Earlier, she has also served on the staff of several federal regulatory agencies, including the Food and Drug Administration, the Office of Management and Budget and the Environmental Protection Agency.
Ducca has a BA in Mathematics from Boston College and a MS in Biostatistics from Georgetown University.
Jeff has been involved in software development for the manufacturing and healthcare industries for 32 years. He joined Cardinal Health in 1997, supporting their pharmaceutical distribution business, and over the last eight years has been managing software solutions development for regulatory-related needs. He began his serialization involvement in 2008 to lead serialization and track-and-trace solution development for California and federal regulations.
Jeff is an active participant in GS1 and HDA. He is a graduate of Le Moyne College in Syracuse, N.Y., where he received his BS in Computer Science.